Gan & Lee Pharmaceuticals. (603087.SS)
CNY 47.69
(-1.63%)
CNY 47.69
(-1.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 340.06 Million CNY | 177.37% |
| 2022 | -439.51 Million CNY | -130.25% |
| 2021 | 1.45 Billion CNY | 18.04% |
| 2020 | 1.23 Billion CNY | 5.43% |
| 2019 | 1.16 Billion CNY | 24.98% |
| 2018 | 933.96 Million CNY | -13.52% |
| 2017 | 1.07 Billion CNY | 40.32% |
| 2016 | 769.63 Million CNY | 72.01% |
| 2015 | 447.42 Million CNY | 46.59% |
| 2014 | 305.21 Million CNY | 49.09% |
| 2013 | 204.72 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 202.89 Million CNY | 111.34% |
| 2024 Q1 | 96 Million CNY | 30.45% |
| 2024 Q3 | 208.36 Million CNY | 2.69% |
| 2023 Q3 | 132.32 Million CNY | 55.8% |
| 2023 Q1 | 49.22 Million CNY | 291.45% |
| 2023 Q2 | 84.93 Million CNY | 72.54% |
| 2023 Q4 | 73.59 Million CNY | -44.38% |
| 2023 FY | 340.06 Million CNY | 177.37% |
| 2022 Q1 | 113.29 Million CNY | -80.51% |
| 2022 FY | -439.51 Million CNY | -130.25% |
| 2022 Q2 | -310.9 Million CNY | -374.41% |
| 2022 Q4 | -25.71 Million CNY | 88.11% |
| 2022 Q3 | -216.19 Million CNY | 30.46% |
| 2021 FY | 1.45 Billion CNY | 18.04% |
| 2021 Q4 | 581.34 Million CNY | 16.59% |
| 2021 Q3 | 498.64 Million CNY | 172.94% |
| 2021 Q2 | 182.69 Million CNY | -3.89% |
| 2021 Q1 | 190.07 Million CNY | -65.09% |
| 2020 Q1 | 123.11 Million CNY | -75.66% |
| 2020 FY | 1.23 Billion CNY | 5.43% |
| 2020 Q4 | 544.5 Million CNY | 43.84% |
| 2020 Q3 | 378.55 Million CNY | 105.14% |
| 2020 Q2 | 184.53 Million CNY | 49.89% |
| 2019 Q1 | 97.66 Million CNY | 0.0% |
| 2019 FY | 1.16 Billion CNY | 24.98% |
| 2019 Q4 | 505.79 Million CNY | 28.45% |
| 2019 Q3 | 393.77 Million CNY | 131.58% |
| 2019 Q2 | 170.04 Million CNY | 74.1% |
| 2018 FY | 933.96 Million CNY | -13.52% |
| 2017 Q2 | 185.72 Million CNY | 0.0% |
| 2017 FY | 1.07 Billion CNY | 40.32% |
| 2017 Q1 | 185.72 Million CNY | 0.0% |
| 2016 FY | 769.63 Million CNY | 72.01% |
| 2015 FY | 447.42 Million CNY | 46.59% |
| 2014 FY | 305.21 Million CNY | 49.09% |
| 2013 FY | 204.72 Million CNY | 0.0% |